Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000841 · ClinicalTrials.gov registry record · NA
Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR)
A NA study of Behavior, sponsored by IRIS Media.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
- 1
- Study location
NCT04000841: Completed NA study of Behavior, sponsored by IRIS Media.
NCT04000841 is a NA study of Behavior that has completed, run by IRIS Media. The registered enrollment target is 212 participants, below the 4,856-participant average among 23 other Behavior trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04000841, a NA study of Behavior, has completed, sponsored by IRIS Media.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
- 1
- Study location
Study Summary
Over a 12-week period the investigators will test whether, compared to the Waitlist-Control (WC) condition, administration of the full CRSR intervention improves participants self-reported outcomes of stress, self-efficacy, mindfulness, use of mindfulness strategies, and knowledge. The investigators also will examine the usability, cultural relevance, and user satisfaction.
Primary Outcome
Stress will be assessed using the Perceived Stress Scale (PSS), a 10-item frequency scale that evaluates the amount of stress in one's life.Scale ranges from 1 (never) to 4 (very often) with higher scores indicating more stress, therefore decreases at posttest would indicate better outcomes. The scores are averaged to get a total score on the scale which has good internal reliability (alpha = .90 in Phase I).
Conditions Studied
Interventions
- BEHAVIORAL Mindful You mobile app
Study Locations (1)
Oregon
- IRIS Educational Media - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2022-02-22 |
| Phase | NA |
What the finished NCT04000841 record still lists
NCT04000841 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 4,856-participant average among 23 other Behavior trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Behavior appearing as the primary indexed condition, and to 1 intervention - of which Mindful You mobile app is the first listed.
NCT04000841 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04000841 about?
NCT04000841 is a clinical study titled "Culturally Responsive Stress Reduction: A Mobile Mindfulness Application for African Americans (CRSR)". Over a 12-week period the investigators will test whether, compared to the Waitlist-Control (WC) condition, administration of the full CRSR intervention improves participants self-reported outcomes of stress, self-efficacy, mindfulness, use of mindfulness strategies, and knowledge. The investigators...
What is the current status of trial NCT04000841?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2021-02-01. Estimated completion is 2022-02-22.
What conditions does trial NCT04000841 study?
This clinical trial studies the following conditions: Behavior.
What interventions are being tested in trial NCT04000841?
The interventions under investigation include: Mindful You mobile app (BEHAVIORAL).
Who is sponsoring clinical trial NCT04000841?
This trial is sponsored by IRIS Media, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04000841 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04000841's enrollment target sits among peer trials
212 10th of 23 higher than 14 of 23 other Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures
RECRUITING · NA
-
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
RECRUITING · NA
-
Pilot Trial of the RUBI Program for Autistic Adults
RECRUITING · NA
-
Studies of Human Inference Using On-line Testing
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
-
Modulating Reward Learning Using Transcranial Magnetic Stimulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI